CHTF
6.8.2024 03:01:29 CEST | Business Wire | Press release
The 26th China Hi-tech Fair (CHTF2024) will take place on November 14-16, 2024 in Shenzhen China. This year’s fair promises to be a groundbreaking event, covering approximately 400,000m2 and attracting over 5,000 renowned enterprises and international organizations from more than 100 countries and regions. CHTF2024 will feature multiple exhibition zones covering AI and robotics, clean energy, high-end medical devices, China’s leading heavy equipment, top tech industry chains, etc.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240802870555/en/
Global Buyer Invitation Programme of the 26th China Hi-tech Fair (CHTF2024) (Graphic: Business Wire)
China has solidified its position as a global technology powerhouse, with significant advancements in AI, big data, 5G, and clean energy. CHTF serves as a vital platform for debuting innovations and facilitating exchanges. In 2024, the ultimate platform invites global powerful exhibitors to win business for innovation in China’s huge tech market.
To ensure the maximum value for exhibitors, buyers, and visitors, CHTF has launched a comprehensive Global Buyer Invitation Programme, which will invite nearly 500 international buyer delegations from Europe, America, Southeast Asia, the Middle East, and other regions. The anticipated 500,000 professional visitors will create an unparalleled opportunity for business growth and networking.
Key Highlights of The Programme:
- International and Domestic Buyer Delegations: The event collaborates with prestigious buyer delegations formed by state-owned enterprises, industry leaders, and international corporations, including PetroChina (CNPC), China National Offshore Oil Corporation (CNOOC), CIPR-The conference “Digitalization of Industrial Russia”, Australian Trade & Investment Commission, etc.
- Tailored Matchmaking: Customized procurement matchmaking events and industry-specific conferences will be held to cater to the precise needs of domestic and international buyers.
- Extensive Buyer Outreach: The organizer will collect the specific procurement requirements of high-quality buyers in advance and meticulously select qualified exhibitors to ensure that the matchmaking process is precise and effective.
- Exclusive Buyer Benefits: The registered purchasers can enjoy a range of perks, including VIP privileges, streamlined entry, pre-arranged meetings with exhibitors, complimentary gifts and meals, transportation, and hotel accommodations, and additionally, a chance of lucky draw for signing contracts on-site. (Buyer benefits are subject to change without notice. Please consult the organizer for details.)
With unwavering Shenzhen government backing, extensive industry support, and proven track records of success, CHTF2024 is poised to be the premier destination to explore cutting-edge technologies, foster business collaborations, and contribute to the future of global industries.
Exhibitor registration: https://c.zhenweiexpo.com/web-reg-server/pc/exhibit-apply.html?EID=E0000000413&target=4&orgnum=1164&pid=1028&version=2&cid=&ctid=1#/index
Visitor registration: https://c.zhenweiexpo.com/web-reg-server/pc/vistor-register.html?EID=E0000000413&target=1&orgnum=1164&pid=1028&version=2&cid=&ctid=1#/index
Follow us on Facebook/LinkedIn/X for updates.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240802870555/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics8.4.2026 07:00:00 CEST | Press release
Hyaluronic acid product for knee osteoarthritis available in the EU and Switzerland from May 2026 Croma-Pharma is returning to the orthopaedics market with the reacquisition of Synocrom™, a hyaluronic acid product for the treatment of knee osteoarthritis. A strategic return built on proven heritage With the reacquisition of Synocrom™, Croma-Pharma is re-entering orthopaedics and further broadening its portfolio in a field with strong historical roots for the company. Until 2014, Croma was active in orthopaedics, with Synocrom™ serving as a key pillar of its offering. Synocrom™ is not a new name in the market. During the period in which Croma actively marketed the product, it became one of the leading hyaluronic acid brands in Europe and ranked among the top brands in its category. Its return therefore represents more than a portfolio expansion: it marks the continuation of a successful orthopaedic legacy and reconnects Croma with an important part of its history. The reintroduction of
Murata Begins Mass Production of Seven Automotive MLCCs with World-leading Capacitance for Their Rated Voltage and Size, Supporting Stable Operation of In-vehicle Systems and Greater Design Flexibility8.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun mass production of seven AEC-Q200-qualified multilayer ceramic capacitors (MLCCs) that achieve the world’s largest capacitance for a given rated voltage and size*, supporting stable operation of in-vehicle systems and greater design flexibility. Five parts in the GCM series are rated at 2.5-4 Vdc, targeting IC peripheral circuits in advanced driver assistance systems (ADAS) and autonomous driving (AD) applications. The remaining two MLCCs are rated at 25 Vdc for in-vehicle power line applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407486750/en/ [Murata Manufacturing Co., Ltd.] Seven automotive MLCCs In recent years, as ADAS and AD technologies advance, the number and performance level of systems installed in vehicles have continued to increase. As a result, demand for higher capacitance low-voltage MLCCs used around ICs has grown to e
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)7.4.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees. The equity awards were granted on April 1, 2026 and consisted of options to purchase an aggregate of 117,445 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 55,875 shares. The options have an exercise price per share equal to $5.62, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s
SLB OneSubsea and Subsea7 Sign Collaboration Agreement with PETRONAS Suriname7.4.2026 22:05:00 CEST | Press release
Partnership enables early engagement to co-develop cost-effective solutions and accelerate subsea development in Suriname Global energy technology company SLB (NYSE: SLB) today announced the signing of a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331210557/en/ SLB OneSubsea has signed a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea soluti
Nadia Karkar Joins 500 Global as Managing Partner7.4.2026 19:43:00 CEST | Press release
Former TPG Rise executive joins as Managing Partner as the firm expands its global investment platform. 500 Global today announced the appointment of Nadia Karkar as Managing Partner as the firm expands its global investment platform. Nadia’s appointment follows the recent announcement of the appointment of Atul Mehta — former Chief Investment Officer of the International Finance Corporation — to 500 Global's Board of Directors, and reflects the firm's continued build-out of the leadership and capabilities required to deliver on its next stage of global growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407719214/en/ Nadia Karkar Joins 500 Global as Managing Partner Nadia joins from TPG Rise, the $31 billion impact investing platform of TPG Inc., where she most recently served as Head of Business Development, responsible for product innovation, strategic partnerships and corporate development. She played a central rol
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom